Navigation Links
Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010
Date:9/7/2010

SAN DIEGO, Sept. 7 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:


  • Morgan Stanley Global Healthcare ConferenceDate:  Tuesday, September 14, 2010 Time:  10:55am Eastern Time (7:55am Pacific Time)Place:  Grand Hyatt Hotel in New York City Speaker:  Ted Schroeder, President & CEO


  • Stifel Nicolaus Healthcare Conference 2010Date:  Thursday, September 16, 2010Time:  8:00am Eastern Time (5:00am Pacific Time)Place:  Four Seasons Hotel in BostonSpeaker:  Ted Schroeder, President & CEO


  • UBS Global Life Sciences ConferenceDate:  Wednesday, September 22, 2010Time:  10:00am Eastern Time (7:00am Pacific Time)Place:  Grand Hyatt Hotel in New York CitySpeaker:  William R. LaRue, SVP & CFO


  • JMP Securities Healthcare ConferenceDate:  Monday, September 27, 2010Time:  10:00am Eastern Time (7:00am Pacific Time)Place:  The New York Palace Hotel in New York CitySpeaker:  Ted Schroeder, President & CEOEach presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page.  A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

    About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com. Contacts:

    William R. LaRue

    SVP, CFOCadence Pharmaceuticals, Inc.

    858-436-1400
    '/>"/>


  • SOURCE Cadence Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
    2. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
    3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
    4. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
    5. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
    6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
    7. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
    8. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
    9. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
    10. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
    11. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
    (Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
    (Date:9/18/2017)... Mich. , Sept. 18, 2017  PMD Healthcare ... Specialty Pharmacy of Kalamazoo, Mich. , ... hub service that expedites and streamlines patient and provider ... PD 2.0, and wellness management services.  ... device used to measure lung function for a variety ...
    Breaking Medicine Technology:
    (Date:9/21/2017)... ... September 21, 2017 , ... Preora Diagnostics Inc. , ... tests, has received two prestigious recognitions that acknowledge the promise of its PWS ... Preora has been named a Top 100 Finalist for the 16th annual Chicago ...
    (Date:9/21/2017)... ... September 21, 2017 , ... A ... addiction recovery at a time when Virginia faces an opioid epidemic. ... a staggering increase of 38 percent from 2015, underscoring the need for additional ...
    (Date:9/21/2017)... TX (PRWEB) , ... September 21, 2017 , ... ... senior housing operators, announces the acquisition of Isle at Kingwood Assisted Living and ... Kingwood is an established retirement community with 55 assisted living apartments, 43 memory ...
    (Date:9/21/2017)... ... September 21, 2017 , ... In the inaugural 30-minute ... Emeritus Professor of Education Gregory A. Smith examines student privacy issues with University ... Switch: Schoolhouse Commercialism, Privacy, and the Failure of Policymaking . , Join ...
    (Date:9/20/2017)... ... September 20, 2017 , ... FirstAlign ... (CoE) with the latest Artificial Intelligence (AI) thinking, announced today the launch of ... easy access to essential information that offers a more comprehensive understanding of the ...
    Breaking Medicine News(10 mins):